404
Equine Pharmaceuticals And Supplements Market Report
The market is projected to grow from USD 898.04 million in 2021 to USD 1,194.31 million by 2028.
Zoetis (The US), Boehringer Ingelheim (Germany), Merck & Co (The US), Elanco Bayer (The US), Ceva Sante Animale (France), Virbac (France), Vetoquinol (France), Affymetrix (The US), and Celltrion (South Korea) are among the key players in the market.
The market is expected to grow at an impressive CAGR of 4.12% in the coming years.
Growing awareness regarding equine pharmaceuticals and supplements products and rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products are some of the factors driving the growth of the market.
Asia Pacific market garnered a significant market share in 2021 and is projected to grow at a healthy CAGR during the assessment period.
The pharmaceuticals segment is expected to register the fastest CAGR in the market.
Equine pharmaceuticals and supplements companies, Equine pharmaceuticals and supplements vendors, Horse owners and sellers, Horse riding event organizations, Horse race competition organizations are the target audience in the market.